This is the first study to explore the relationship between EMT and the ICI response in the context of PD-L1 expression and has demonstrated that EMT may play a role as a predictive biomarker for ICI therapy in patients with PD-L1-high NSCLC. Here, CD274 is linked to non-small cell lung carcinoma.